Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review)

被引:0
|
作者
Dai, Chunfei [1 ,2 ]
Qianjiang, Haoyue [1 ,2 ]
Fu, Ruishuang [1 ]
Yang, Huimin [1 ]
Shi, Aiqin [3 ]
Luo, Huacheng [1 ]
机构
[1] Chinese Acad Sci, Zhejiang Canc Hosp, Hangzhou Inst Med, Key Lab Zhejiang Prov Aptamers & Theranost, 150 Fucheng Rd, Hangzhou 310022, Zhejiang, Peoples R China
[2] Zhejiang Univ Technol, Coll Pharm, Hangzhou 310014, Zhejiang, Peoples R China
[3] Xianghu Lab, Hangzhou 311231, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
long non-coding RNA; chromatin modification; epigenetic regulation; epitranscriptomic regulation; carcinogenesis; LONG NONCODING RNA; BREAST-CANCER CELLS; DNA METHYLATION; PROSTATE-CANCER; UNIQUE FEATURES; GENE-REGULATION; CHROMATIN; EXPRESSION; PROLIFERATION; METASTASIS;
D O I
10.3892/ijo.2025.5735
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Long non-coding RNAs (lncRNAs) are key players in the regulation of gene expression by mediating epigenetic and epitranscriptomic modification. Dysregulation of lncRNAs is implicated in tumor initiation, progression and metastasis. lncRNAs modulate chromatin structure and gene transcription by recruiting epigenetic regulators, including DNA- or histone-modifying enzymes. Additionally, lncRNAs mediate chromatin remodeling and enhancer-promoter long-range chromatin interactions to control oncogene expression by recruiting chromatin organization-associated proteins, thereby promoting carcinogenesis. Furthermore, lncRNAs aberrantly induce oncogene expression by mediating epitranscriptomic modifications, including RNA methylation and RNA editing. The present study aimed to summarize the regulatory mechanisms of lncRNAs in cancer to unravel the complex interplay between lncRNAs and epigenetic/epitranscriptomic regulators in carcinogenesis. The present review aimed to provide a novel perspective on the epigenetic and epitranscriptomic roles of lncRNAs in carcinogenesis to facilitate identification of potential biomarkers and therapeutic targets for cancer diagnosis and treatment.
引用
收藏
页数:15
相关论文
共 50 条
  • [11] Epigenetic and Epitranscriptomic Regulation of HIV infection
    Rana, T.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2019, 14 (02) : 332 - 332
  • [12] Epigenetic and Epitranscriptomic Control in Prostate Cancer
    Lopez, Judith
    Anazco-Guenkova, Ana M.
    Monteagudo-Garcia, Oscar
    Blanco, Sandra
    GENES, 2022, 13 (02)
  • [13] A review on the role of PCA3 lncRNA in carcinogenesis with an especial focus on prostate cancer
    Ghafouri-Fard, Soudeh
    Khoshbakht, Tayyebeh
    Hussen, Bashdar Mahmud
    Baniahmad, Aria
    Taheri, Mohammad
    Rashnoo, Fariborz
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 231
  • [14] Role of Epitranscriptomic and Epigenetic Modifications during the Lytic and Latent Phases of Herpesvirus Infections
    Soto, Abel A.
    Ortiz, Gerardo
    Contreras, Sofia
    Soto-Rifo, Ricardo
    Gonzalez, Pablo A.
    MICROORGANISMS, 2022, 10 (09)
  • [15] The Role of Epigenetic Alterations in Papillary Thyroid Carcinogenesis
    Eze, Ogechukwu P.
    Starker, Lee F.
    Carling, Tobias
    JOURNAL OF THYROID RESEARCH, 2011, 2011
  • [16] Genetic and epigenetic influences in prostatic carcinogenesis - (Review)
    Hayward, SW
    Grossfeld, GD
    Tlsty, TD
    Cunha, GR
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (01) : 35 - 47
  • [17] Epigenetic and epitranscriptomic regulation of meiosis and the preimplantation embryo
    Klungland, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 766 - 766
  • [18] An Emerging Role for Epigenetic Dysregulation in Arsenic Toxicity and Carcinogenesis
    Ren, Xuefeng
    McHale, Cliona M.
    Skibola, Christine F.
    Smith, Allan H.
    Smith, Martyn T.
    Zhang, Luoping
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2011, 119 (01) : 11 - 19
  • [19] epidecodeR: a functional exploration tool for epigenetic and epitranscriptomic regulation
    Joshi, Kandarp
    Wang, Dan O.
    BRIEFINGS IN BIOINFORMATICS, 2024, 25 (02)
  • [20] A review on the role of DANCR in the carcinogenesis
    Ghafouri-Fard, Soudeh
    Khoshbakht, Tayyebeh
    Hussen, Bashdar Mahmud
    Baniahmad, Aria
    Taheri, Mohammad
    Samadian, Mohammad
    CANCER CELL INTERNATIONAL, 2022, 22 (01)